Research progress of radiation therapy for oligo-metastatic prostate cancer / 中华泌尿外科杂志
Chinese Journal of Urology
; (12): 317-320, 2023.
Artigo
em Chinês
| WPRIM (Pacífico Ocidental)
| ID: wpr-994033
Biblioteca responsável:
WPRO
ABSTRACT
In this report, we have reviewed the research progress in the involvement, efficacy and prediction of biomarkers of radiotherapy in oligo-metastatic prostate cancer. According to the timing of metastasis, oligo-metastases can be divided into four categories de-novo oligo-metastasis, oligo-recurrence, oligo-progression and oligo-persistence. The use of radiotherapy in oligo-metastases of prostate cancer is becoming more and more important, which can be used not only for primary radiotherapy in newly diagnosed oligo-metastasis patients, but also for metastatic radiotherapy in oligo-recurrence patients. In addition, studies are trying to conduct full coverage of primary and metastatic radiotherapy for 4 types of oligometastases.
Texto completo:
Disponível
Base de dados:
WPRIM (Pacífico Ocidental)
Idioma:
Chinês
Revista:
Chinese Journal of Urology
Ano de publicação:
2023
Tipo de documento:
Artigo